« Back to Record
Citation APA

Kenemans, P., Bundred, N. J., Foidart, J.-M., Kubista, E., von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C. H., Egberts, J., Mol-Arts, M., Mulder, R., van Os, B., Beckmann, M. W., & Simon, P. (2009). Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet oncology, 10(2), 135-146. doi:10.1016/S1470-2045(08)70341-3


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156073

Kenemans, P., Bundred, N. J., Foidart, J.-M., Kubista, E., von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C. H., Egberts, J., Mol-Arts, M., Mulder, R., van Os, B., Beckmann, M. W., & Simon, P. (2009). Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet oncology, 10(2), 135-146. doi:10.1016/S1470-2045(08)70341-3